Patients with OSA who initiate continuous positive airway pressure should have an initial follow-up within 1 to 3 weeks of starting CPAP.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Sleeping on your side. This can help if you get mild sleep apnea only when you sleep on your back. Nasal sprays. These can help if sinus problems or nasal congestion make it harder to ...

It's currently in phase three trials, but according to phase two results, AD109 offers meaningful improvements to sleep apnea ...

Research indicates that the prevalence of MetS rises significantly with increasing OSA severity, with rates ranging from 18.6% in mild OSA to 57.1% in severe OSA cases. Conversely, nearly 60.5% of ...

A study has found that moderate-to-severe obstructive sleep apnea increases risk for incident myocardial infarction between 12 and 5:59 AM.

those with CPAP-treated severe OSA, those with CPAP-treated mild-to-moderate OSA, and those with untreated mild-to-moderate OSA. Sensitivity analysis by type of diagnostic sleep study did not ...

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...